Results 161 to 170 of about 48,974 (212)

NLRX1 contributes to immunotherapeutic resistance of head and neck squamous cell carcinoma by suppressing type I interferon pathway. [PDF]

Front Immunol
Wu Y, Jiang Y, Pan D, Zhang Z, Chen Q, Luo X.   +5 more
europepmc   +1 more source

Regulation of the lncRNA NEAT1 by p53-ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC. [PDF]

Mol Oncol
De Domenico S, La Banca V, D'Amico S, Scalera S, Nicolai S, Peschiaroli A.   +5 more
europepmc   +1 more source

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy [PDF]

Cells, 2020
Head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of malignant tumours typically caused by alcohol and tobacco consumption, although an increasing number of HNSCC arise due to persistent infection with high-risk human papilloma virus (HPV).
Simon Laban, Adrian von Witzleben, Chuan Wang   +2 more
exaly   +4 more sources

miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC

Cancers, 2022
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive disease with poor prognosis, which is mainly due to drug resistance. The biology determining the response to chemo-radiotherapy in HNSCC is poorly understood. Using clinical samples, we
Tahir B Dar, Faizan Ahmed, Eric Vail
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Preclinical models of HPV+ and HPV− HNSCC in mice: An immune clearance of HPV+ HNSCC

Head & Neck, 2009
AbstractBackground.To investigate whether human papilloma virus (HPV)‐specific immune mechanisms can result in tumor clearance, we have created HPV+ and HPV− tonsil cells that form squamous cancers in immune‐competent mice. Here, we determine that an immune‐specific response can clear HPV+ tumor cells and the cellular requirements to mediate this tumor
Robin, Williams, Dong Wook, Lee, Bennett D, Elzey, Mary E, Anderson, Bruce S, Hostager, John H, Lee   +5 more
openaire   +2 more sources

Vaccination Expectations in HNSCC

2016
HPV-associated head and neck squamous cell carcinoma (HNSCC), more specifically the incidence of oropharyngeal cancer, is dramatically increasing in industrialized countries. According to what has been learned from anogenital vaccination programs, there are reasons to believe that current human papillomavirus (HPV) vaccinations may be potentially ...
Rautava Jaana, Syrjänen Stina
openaire   +2 more sources

Pattern of Failure Among HNSCC

Bengal Journal of Cancer, 2021
Aim: This retrospective study was conducted to evaluate the pattern of recurrence in head and neck squamous cell carcinoma (HNSCC) patients who received a definitive chemo-radiotherapy. Materials and Methods: In this retrospective study, the data of 308 head and neck patients from ...
Afsana Shah, Dinesh Kumar, Govind Preet Singh, Pragya Shukla   +3 more
openaire   +1 more source